# AstraZeneca Pharmaceuticals LP, Philadelphia, PA – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Philadelphia, Pennsylvania. 9 FDA inspections on record, 1 Form 483, last inspected June 24, 2025.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 3004829714
- Address Line 1: 3001 Red Lion Rd
- City: Philadelphia
- State: Pennsylvania
- Zip Code: 19114
- Country Name: United States
- Address: 3001 Red Lion Rd, Philadelphia, Pennsylvania 19114, United States
- Country: United States

## Related Documents

- [CRL - AstraZeneca Pharmaceuticals LP - Unknown Date](https://www.keypedia.com/records/crl/astrazeneca-pharmaceuticals-lp/f522475b-222d-454f-bb23-a7910b73b215) — source: FDA, date: Invalid Date
- FDA Inspection 1277181 - AstraZeneca Pharmaceuticals LP - 2025-06-24 — source: FDA, date: June 24, 2025
- FDA Inspection 1277181 - AstraZeneca Pharmaceuticals LP - 2025-06-24 — classification: No Action Indicated (NAI), source: FDA, date: June 24, 2025
- [483 - AstraZeneca Pharmaceuticals LP - 2022-07-22](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/cbeb85bf-3ed5-456e-9ea8-d27f7367f0b1) — source: FDA, date: July 22, 2022
- [FDA Inspection 1175133 - AstraZeneca Pharmaceuticals LP - 2022-07-22](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/dae5e2be-5942-4a41-b4a5-3f7bf88d2245) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2022
- [FDA Inspection 1060670 - AstraZeneca Pharmaceuticals LP - 2018-06-20](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/500df3a2-86d2-4a61-9aca-64742d4d4bf0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2018
- FDA Inspection 940375 - AstraZeneca Pharmaceuticals LP - 2015-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2015
- [FDA Inspection 846805 - AstraZeneca Pharmaceuticals LP - 2013-05-22](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/c22f62c3-cfee-4e9e-9f25-b0b365a29274) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2013
- [FDA Inspection 747381 - AstraZeneca Pharmaceuticals LP - 2011-05-03](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/6ef05072-7e87-49c5-b502-be7527582ef6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2011
- [FDA Inspection 671182 - AstraZeneca Pharmaceuticals LP - 2010-06-23](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/11493b37-191a-4fe6-9b02-a0d607b0491e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 23, 2010
- [FDA Inspection 635722 - AstraZeneca Pharmaceuticals LP - 2009-12-07](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/916e88b4-8ef6-48c2-be06-e2f334f1fdb4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2009
- [FDA Inspection 601426 - AstraZeneca Pharmaceuticals LP - 2009-06-16](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/bc5d904d-a3aa-4c0c-8f66-ceb8716194cb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2009

## Related Companies

- [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.](https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f)
- [GlaxoSmithKline Vaccines Srl](https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/3b442668-2065-481f-bc35-a803bb376acc)
- [Octapharma AB](https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262)
- [LifeSouth Community Blood Centers, Inc](https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893)
- [Corixa Corporation](https://www.keypedia.com/companies/corixa-corporation/540054c0-cf35-42d2-9056-a9ae897ff412)
- [Lonza Netherlands B.V.](https://www.keypedia.com/companies/lonza-netherlands-bv/f39deee8-be7f-41a8-b12e-d2cf810de4c1)
- [Humacyte Global Inc](https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)

## Related Officers

- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Mohammed Al-Qasmi](https://www.keypedia.com/people/mohammed-al-qasmi/8324cc78-bb12-4cc0-b74d-35a8e8585f44)